药明生物因期权获行使而发行合计605万股

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 6.05 million ordinary shares on November 25, 2025, as part of the stock option plan adopted prior to its initial public offering on January 5, 2016, which was revised on August 10, 2016 [1] Group 1 - The company is exercising options under its pre-IPO stock option plan [1] - A total of 6.05 million ordinary shares will be issued [1] - The announcement is part of the company's ongoing equity management strategy [1]